Humulin
Payments companies reported to CMS as associated with Humulin. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Humulin, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Humulin
These are the largest totals companies reported as associated with Humulin. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Rosemarie Lajara | Plano, TX | Endocrinology, Diabetes & Metabolism | $2,495.34 |
| Charmian Cohen | Riverhead, NY | Endocrinology, Diabetes & Metabolism | $1,300.00 |
| Zdzislaus Wanski | Branson, MO | Endocrinology, Diabetes & Metabolism | $650.00 |
| Robert Wozniak | Rock Hill, SC | Endocrinology, Diabetes & Metabolism | $246.89 |
| Cindy Huang | Los Angeles, CA | Endocrinology, Diabetes & Metabolism | $218.98 |
| Sawsan Barakat | Northridge, CA | $195.60 | |
| Erica Conley | Florence, AL | Family | $182.31 |
| Debra Davis | Tuscaloosa, AL | Internal Medicine | $170.66 |
| William Debell | Tuscaloosa, AL | Endocrinology, Diabetes & Metabolism | $170.65 |
| Linda Canterbury | Tuscaloosa, AL | Nurse Practitioner | $167.77 |
Prescribed Humulin?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.